Ambrx Inc. Company Profile

12:34 EDT 23rd September 2017 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

Ambrx Appoints Lawson Macartney, Ph.D., DVM, Chief Executive Officer

SAN DIEGO, Jan. 7, 2013 /PRNewswire/ --  Ambrx today announced the appointment of Lawson Macartney, Ph.D., DVM, to president and chief executive officer of the company and a member of the board o...

Ambrx Inc Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAmbrx Inc Ambrx is a biopharmaceutical company which focuses on the discovery and development of proteinbased medicines by using its expanded genetic code. The company's pipeline product candid...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Ambrx Inc.

CMEA Ventures

CMEA Ventures is a San Francisco based venture capital firm that was established in 1989 and specializes in high technology, life sciences, and alternative energy investments. We invest in both early ...

More Information about "Ambrx Inc." on BioPortfolio

We have published hundreds of Ambrx Inc. news stories on BioPortfolio along with dozens of Ambrx Inc. Clinical Trials and PubMed Articles about Ambrx Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ambrx Inc. Companies in our database. You can also find out about relevant Ambrx Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record